Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hendricks

Showing results (311-320 of 323) with videos related to

Pageof 33
Sort By:
Gynecologic Oncology|March 16, 2016
The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic typeLeora Witkowski, Catherine Goudie, Pilar Ramos, et al.
Iscience|February 5, 2025
Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic typeJessica D Lang, William Selleck, Shawn Striker, et al.
Cancer Reports (Hoboken, N.J.)|March 31, 2022
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastomaJacqueline M Kraveka, Elizabeth C Lewis, Genevieve Bergendahl, et al.
Investigational New Drugs|September 29, 2018
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastasesHani M Babiker, Sara A Byron, William P D Hendricks, et al.
Plos Genetics|September 7, 2018
Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysisWilliam P D Hendricks, Victoria Zismann, Karthigayini Sivaprakasam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2018
Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase InhibitionJessica D Lang, William P D Hendricks, Krystal A Orlando, et al.
Cancer Research|May 23, 2025
Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic TypeElizabeth A Raupach, Apurva M Hegde, Krystine Garcia-Mansfield, et al.
Genome Medicine|February 12, 2024
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trialGiselle L Saulnier Sholler, Genevieve Bergendahl, Elizabeth C Lewis, et al.
Nature Genetics|March 25, 2014
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4Pilar Ramos, Anthony N Karnezis, David W Craig, et al.
Cancer Research|October 6, 2021
Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune EvasionSara A Byron, William P D Hendricks, Abhinav B Nagulapally, et al.
Pageof 33

Showing results (311-320 of 323) with videos related to

Sort By:
Pageof 33
Gynecologic Oncology|March 16, 2016
The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic typeLeora Witkowski, Catherine Goudie, Pilar Ramos, et al.
Iscience|February 5, 2025
Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic typeJessica D Lang, William Selleck, Shawn Striker, et al.
Cancer Reports (Hoboken, N.J.)|March 31, 2022
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastomaJacqueline M Kraveka, Elizabeth C Lewis, Genevieve Bergendahl, et al.
Investigational New Drugs|September 29, 2018
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastasesHani M Babiker, Sara A Byron, William P D Hendricks, et al.
Plos Genetics|September 7, 2018
Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysisWilliam P D Hendricks, Victoria Zismann, Karthigayini Sivaprakasam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2018
Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase InhibitionJessica D Lang, William P D Hendricks, Krystal A Orlando, et al.
Cancer Research|May 23, 2025
Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic TypeElizabeth A Raupach, Apurva M Hegde, Krystine Garcia-Mansfield, et al.
Genome Medicine|February 12, 2024
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trialGiselle L Saulnier Sholler, Genevieve Bergendahl, Elizabeth C Lewis, et al.
Nature Genetics|March 25, 2014
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4Pilar Ramos, Anthony N Karnezis, David W Craig, et al.
Cancer Research|October 6, 2021
Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune EvasionSara A Byron, William P D Hendricks, Abhinav B Nagulapally, et al.
Pageof 33